Oncology division

[anonymous]

Me too, I need to wait on the background check to come back and I am out of here. I felt I needed to get out soon before its a fire drill.

 

[anonymous]

Me too, I need to wait on the background check to come back and I am out of here. I felt I needed to get out soon before its a fire drill.

You will not miss Eisai…no one ever regrets leaving…the only regrets are coming here in the first place and staying any longer than ya have to.

 

[anonymous]

We had 3 people resign today. Don't hear anything about that do you! It gets interesting when managers start leaving. They know whats behind the curtain, or coming in March.

 

[anonymous]

Where did they go?

 

[anonymous]

One went to BMS, I don't know where the one in Louisiana went and the other went somewhere like Astrazeneca. We also lost 4 reps. That's all in a week for oncology. I'm wondering if sleeve 3 is gone and some of the 1s and 2s are downsized. We have no pipeline and poor management.

 

[anonymous]

One went to BMS, I don't know where the one in Louisiana went and the other went somewhere like Astrazeneca. We also lost 4 reps. That's all in a week for oncology. I'm wondering if sleeve 3 is gone and some of the 1s and 2s are downsized. We have no pipeline and poor management.

You are right, I just heard the same. Wasn't told where they went but, they are gone. So you must be on the management side. Please tell what is next. I keephearking about a downsizing in the spring. What do you know.

 

[anonymous]

Alex Scott did the dude.

 

[anonymous]

One went to BMS, I don't know where the one in Louisiana went and the other went somewhere like Astrazeneca. We also lost 4 reps. That's all in a week for oncology. I'm wondering if sleeve 3 is gone and some of the 1s and 2s are downsized. We have no pipeline and poor management.

And that tells you all you need to know about Eisai’s reputation…BMS and AZ? Wow. Most good oncology reps are trying to leave those places for biotechs, not go to them. They are both the entry level big pharma of oncology. They don’t even pay well…this place is a disaster if that what people are leaving to.

 

[anonymous]

And that tells you all you need to know about Eisai’s reputation…BMS and AZ? Wow. Most good oncology reps are trying to leave those places for biotechs, not go to them. They are both the entry level big pharma of oncology. They don’t even pay well…this place is a disaster if that what people are leaving to.

Nonsense! We have the great PH, who built Sanofi into the oncology powerhouse it is today……..

 

[anonymous]

Nonsense! We have the great PH, who built Sanofi into the oncology powerhouse it is today……..

Hahahaha

 

[anonymous]

And that tells you all you need to know about Eisai’s reputation…BMS and AZ? Wow. Most good oncology reps are trying to leave those places for biotechs, not go to them. They are both the entry level big pharma of oncology. They don’t even pay well…this place is a disaster if that what people are leaving to.

Nothing for nothing but AZ may have best pipeline in industry.

 

[anonymous]

Nothing for nothing but AZ may have best pipeline in industry.

So what? Is that what gets you excited? Pipeline? Most oncology reps are on the hunt for a biotech startup with one drug that launches successfully and brings them a buyout with a big payout...then comes the retention bonus, all the while that crew is scouting the next buildout.

AZ, Merck, GSK, Pfizer, etc pay substantially less in base, bonus, equity and sign on, all the while going about the business in a big pharma primary care micromanaged way.

Eisai reps are not being recruited for those opportunities...for good reason.

 

[anonymous]

So what? Is that what gets you excited? Pipeline? Most oncology reps are on the hunt for a biotech startup with one drug that launches successfully and brings them a buyout with a big payout...then comes the retention bonus, all the while that crew is scouting the next buildout.

AZ, Merck, GSK, Pfizer, etc pay substantially less in base, bonus, equity and sign on, all the while going about the business in a big pharma primary care micromanaged way.

Eisai reps are not being recruited for those opportunities...for good reason.

Just went to AZ and got a lot more money and guarantee LTI every year. You do not know what you are talking about. Stay at Eisai please!

 

[anonymous]

Just went to AZ and got a lot more money and guarantee LTI every year. You do not know what you are talking about. Stay at Eisai please!

Same here but I also negotiated for honey wine and charcuterie to be placed in my room at all sales meetings

 

[anonymous]

Just got an offer from Merck and it was a lot more, plus better benefits. Called my manager and she said I was making more than her.

 

[anonymous]

Just went to AZ and got a lot more money and guarantee LTI every year. You do not know what you are talking about. Stay at Eisai please!

Yet you are still making a lot less than the reps at the good biotechs...one of your chief competitors in RCC is paying reps well over $220K, $65K at plan, $100K a year in LTI.

I have a close friend who is a 2L manager at AZ and he said they can't recruit the tenured biotech oncology reps that they would love to be able to hire since they cannot pay them close to what they are currently making. Reps as those companies are making more in a year than he is as a 2L leader at AZ, so they recruit reps from other big pharmas, give them a 20% raise and they think they hit the motherland.

I guess this proves that money is all relative...

 

[anonymous]

I went to Stemline, wow what a difference. I make a lot more money, better product and something more important, we have a pipeline.

 

[anonymous]

I went to Stemline, wow what a difference. I make a lot more money, better product and something more important, we have a pipeline.

Omg that’s funny…..a pipeline. Be honest yes you make more money but the product and company sucks. That is the trade off when you go to biotech. I have multiple times and that is the result. At least just say it’s only about money and you will be respected. Nothing wrong with that.

 

[anonymous]

Omg that’s funny…..a pipeline. Be honest yes you make more money but the product and company sucks. That is the trade off when you go to biotech. I have multiple times and that is the result. At least just say it’s only about money and you will be respected. Nothing wrong with that.

So you are saying the big pharma culture is better than the startup biotech’s?

You are insane if you think that.

 

[anonymous]

Omg that’s funny…..a pipeline. Be honest yes you make more money but the product and company sucks. That is the trade off when you go to biotech. I have multiple times and that is the result. At least just say it’s only about money and you will be respected. Nothing wrong with that.

You are the funny one. You have a product that is terrible and a company that is even worse. What do you do when the patient runs out on Lenvima?You are a one trick pony.